digital currency 2019 Top Featured snippets

Gong Zheng, Mayor of Shanghai, investigates Shanghai Electric Group: If the growth point of emerging industries is identified, he will increase investment and cultivate growth. Gong Zheng, Deputy Secretary of Shanghai Municipal Committee and Mayor, pointed out in the investigation of Shanghai Electric Group today (13th) that Shanghai Electric bears the great mission of innovation and development of high-end equipment industry, and should further focus on its main business, make efforts to "strengthen the foundation and revitalize the new", make the energy level bigger and stretch the long board longer. Consolidating the foundation is to focus on consolidating the basic disk of high-end equipment manufacturing, enhance the initiative of transformation in advantageous areas, increase the intensity of transformation, and expand domestic and foreign markets. Promoting innovation is to focus on cultivating the growth point of emerging industries, increase investment when it is clear, cultivate and grow as soon as conditions are ripe, take the lead in seizing the commanding heights, and strive to break new paths and advance in promoting new industrialization and cultivating new quality productivity. (The Paper)Market News: The United Arab Emirates will restrict oil transportation in the case of OPEC+promoting compliance with quotas.Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.

Peng Qinghua met with Babacov, Vice Chairman of Russian State Duma, and Peng Qinghua, Vice Chairman of the National People's Congress Standing Committee (NPCSC), met with Babacov, Vice Chairman of Russian State Duma, in Beijing on the 13th. The two sides indicated that they will jointly implement the important consensus reached by the two heads of state, make good use of the platform of the joint working group of the Sino-Russian Parliamentary Cooperation Committee, deepen exchanges and cooperation between legislative bodies, and promote the further development of China-Russia comprehensive strategic partnership of cooperation in the new era. (Xinhua News Agency)Jinghe Jicheng: Shareholder Lijing Venture Capital intends to transfer 1.50% shares of the company by inquiry, and Jinghe Jicheng announced that shareholder Lijing Venture Capital intends to transfer 30.092 million shares of the company by inquiry transfer, accounting for 1.50% of the company's total share capital.Liu Jianchao met with Egyptian Foreign Minister Abdul Ati. On December 13th, Liu Jianchao, Minister of the International Liaison Department of the CPC Central Committee, met with Egyptian Foreign Minister Abdul Ati in Beijing. The two sides exchanged views on implementing the important consensus of the two heads of state, strengthening inter-party exchanges, strengthening political dialogue and humanities exchanges, and promoting the construction of a community of destiny between China and Egypt facing the new era. (Xinhua News Agency)

Bei Ya raised the Amazon target price from $220.00 to $260.00.France's new Prime Minister Bayrou: I know my task is arduous, and we need to unite the people. Everyone knows that this road will be long.Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.